ClinicalTrials.gg
RecruitingNCT05088863Updated Nov 29, 2024

Survey Assessing How Consumers Adapt Their Diet in Response to Health Claim Messaging

An interventional study of flaxseed in Health Claim Implementation, sponsored by St. Boniface Hospital. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-29.

Sponsored by St. Boniface Hospital · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Nov 2025, 1 year ago, but the record still lists the study as recruiting.
  • Started Mar 2022; still recruiting 4 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
384
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

A survey designed to examine how consumers adapt their diet in response to health claim messaging.

Read the detailed description

384 participants will be recruited to participate (n=32/group) ensuring equal numbers based on gender (men and women), income (low and medium-high), and age (18-35, 36-55, >56 years). Participants will be asked to prepare a 3-day food record representative of their current dietary intake. Participants will then be told, "Health Canada has approved the following health claim: 40g of ground flaxseed per day has been shown to help lower cholesterol, which is a risk factor for heart disease." Without any further guidance, participants will then be asked to modify their diet to achieve 40g per day of flaxseeds for the following 2 weeks. They will be asked to prepare another 3-day food record so we can see if/how their diet changed. At the end of the 2-week period, participants will be asked if they were successful with the changes and what barriers they faced in implementing these changes. This survey will be accomplished remotely with informed consent and communication with participants happening over the phone or videoconference. Participants will mail the food records to clinical trial staff. Analysis of food records will identify the food choices used to achieve dietary change, if these changes altered nutrient intake compared to their usual diet and if they were able to achieve the target laid out (ie. 40g flaxseed per day). A questionnaire will be used to identify barriers to implementation of dietary change (ie. price, availability, sensory aspects of food, ease of preparation).

02

Conditions studied

  • Health Claim Implementation

Keywords

  • health claim
  • flax
03

In context

Lead sponsor

St. Boniface Hospital is the lead sponsor of 32 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Man or woman, age ≥18 years;
  2. Willing to provide ;
  3. Willing/able to comply with the requirements of the study;
  4. Have a mailing address in the Winnipeg census metropolitan area (City of Winnipeg and the municipalities of West St. Paul, East St. Paul, Headingley, Macdonald, Richot, Tache, Springfield, Rosser, St. Francois Xavier and St. Clements)4.

Exclusion criteria

Exclusion Criteria:

  1. Allergy, aversion or unwillingness to eat whole ground flaxseed;
  2. Consuming ≥40g whole ground flaxseed/day;
  3. A family member within the same household is participating or has participated in this study;
  4. Currently participating in a food trial or dietary program that does not allow change in food choice.
  5. Pregnant or lactating
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
384 participants (estimated)

Study arms

  • Other
    Implementation of health claim

    Participants will have 2 weeks to incorporate 40g of flaxseed per day into their diet

    Other: flaxseed

Interventions

  • Otherflaxseed

    40g of flaxseed per day

06

What researchers measure

Primary outcomes

  1. 3-day food record to assess food choices to achieve health claim

    A list of flax containing foods from the 3-day food record will be created and the frequency with which each food item was selected will be recorded.

    Time frame: Two weeks

  2. Comparison of 3-day food records to assess change in nutrient intake from usual diet to diet addressing health claim

    3 day food records before and after change in diet to address health claim will be entered into nutrition analysis software to calculate nutrient intake

    Time frame: Four weeks

  3. Were they able to achieve the target laid out in the health claim

    Questionnaire to identify barriers to implementation of health claim

    Time frame: 2 weeks

Secondary outcomes

  1. Barriers to implementation of dietary change

    Questionnaire to identify if price, availability, sensory aspects of food, ease of preparation are barriers to implementation of the health claim

    Time frame: 2 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Kaur A, Scarborough P, Rayner M. A systematic review, and meta-analyses, of the impact of health-related claims on dietary choices. Int J Behav Nutr Phys Act. 2017 Jul 11;14(1):93. doi: 10.1186/s12966-017-0548-1. PubMed 28697787 ↗

Individual participant data

Plan to share: Yes — All IPD that underlie results in a publication

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: From the time the data is collected until the manuscript is accepted for publication

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2022 (actual). Primary completion is estimated for Nov 2025, 44 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 6, 2021
First posted
Oct 22, 2021
StartActual
Mar 3, 2022
Primary completionEst.
Nov 2025
CompletionEst.
Nov 2025
Last update
Nov 29, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05088863
Lead sponsor
St. Boniface Hospital
Collaborators
Agriculture and Agri-Food Canada
Responsible party
Dr. Heather Blewett (Principal Investigator, St. Boniface Hospital) — Principal investigator
First posted
Oct 22, 2021
Start date
Mar 3, 2022
Primary completion
Nov 2025 (estimated)
Completion
Nov 2025 (estimated)
Last update
Nov 29, 2024

Study contacts

Heather Blewett, PhD
Contact
heather.blewett@agr.gc.ca
204 237-2954
Jo-Ann Stebbing, MSC
Contact
jstebbing@sbrc.ca
204 258-1209
Heather Blewett, PhD
principal investigator · Agriculture and Agri-Food Canada

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion